What is compounded semaglutide and is it safe?

Compounding is pharmacy-prepared medication — a practice as old as pharmacy itself, used whenever a patient needs something the factory product doesn’t offer: a different strength, a custom titration step, an added ingredient, or a different form (like sublingual tablets). The safety question splits into three tiers: 1. 503B outsourcing facilities — FDA-registered, manufacturing-grade quality standards, FDA-inspected. The highest bar. 2. 503A compounding pharmacies — state-licensed, patient-specific prescriptions. Quality is generally good but oversight is state-level and more variable. 3. Not compounding at all: “research chemical” sites, peptide vendors, gray-market imports. These wear the vocabulary of compounding while being unlicensed drug sales — this is where the horror stories (wrong doses, no semaglutide at all, contamination) actually come from. How to tell them apart. The legal context matters: during the 2022–2024 shortages, pharmacies could compound near-copies at scale. The shortages are resolved, so today’s legitimate compounded semaglutide is prescribed when a clinician documents an individual need — a custom dose, slower titration, B6 addition, or sublingual form. Programs operating carefully in that lane (with real prescriber screening and named pharmacies) are a legitimate, dramatically cheaper route; the full analysis is in compounded vs. brand. Known trade-offs even at good pharmacies: no FDA review of the specific formulation, batch-to-batch consistency below factory standards, and occasional dosing-error reports (FDA has flagged patient confusion with vial-and-syringe dosing — ask your program to demonstrate your exact draw).